FDG-PET shows promise for planning merkel cell carcinoma treatment

08/14/2013 | AuntMinnie.com (free registration)

A study in the Journal of Nuclear Medicine found FDG-PET could be effective in the staging and management of merkel cell carcinoma. Researchers at the University of Melbourne analyzed data from patients who underwent FDG-PET scans using PET or PET/CT imaging. They recorded patients' management plans before and after the imaging procedures and retrospectively recorded the follow-up outcomes. Tumor staging scans with FDG-PET led to a treatment change in 37% of patients. Among 23 scans considered to have a substantial impact, 62% led to a change in treatment modality, 21% influenced treatment intent and 17% led to changes in treatment modality plus the technique for radiation therapy.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC